It has been found that decreased hepatic glycogen synthesis in the liver is accompanied by a significant increase in all indicators of liver fibrosis, and rosiglitazone and insulin promote hepatic glycogen synthesis and inhibits hepatic glucose isomerization. Here, INS is linked to Hepatic fibrosis.